- Nicotine patch
-
A nicotine patch is a transdermal patch that releases nicotine into the body through the skin. It is used as an aid in nicotine replacement therapy (NRT), a process for smoking cessation. The first published study of the pharmacokinetics of a transdermal nicotine patch in humans was authored by Jed E. Rose, Ph.D., Murray E. Jarvik, M.D., Ph.D. and K. Daniel Rose, M.D., in the journal Drug and Alcohol Dependence (vol. 13, pp.209-213, 1984). This was followed by publication of results of a study of smokers showing that a transdermal nicotine patch reduced craving for cigarettes (Rose JE, Herskovic JE, Trilling Y and Jarvik ME, Clinical Pharmacology and Therapeutics, vol. 38, pp. 450-456, 1985). The University of California filed a patent application in April, 1985 that was granted in 1991 (U.S. Patent #4,920,989). However, a competing patent application, filed by Dr. Frank T. Etscorn III, was issued on July 1, 1986 (U.S. Patent #4,597,961). Subsequently, the U.S. Patent Office declared an interference action and, on September 29, 1993, issued a priority decision in favor of the Rose et al. patent.
Contents
Issues
Efficacy
Dozens of clinical trials have shown that the patch approximately doubles success rates over placebo treatment [Fiore MC, Jaén CR, Baker TB, et al. Treating Tobacco Use and Dependence: 2008 Update. Quick Reference Guide for Clinicians. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service. April 2009].
Alternate uses
Nicotine patches are under study to help relieve the symptoms of post-surgical pain.[1]
See also
- Murray Jarvik
- Smoking cessation
- Nicotine replacement therapy
- Nicotine lozenge
- Nicotine gum
- Transdermal patch
- Nicoderm CQ
References
Routes of administration / Dosage forms Oral Buccal / Sublabial / Sublingual- Mouthwash
- Toothpaste
- Ointment
- Oral spray
- Oxygen mask
- Oxygen concentrator
- Anaesthetic machine
- Relative analgesia machine
Ocular / Otologic / Nasal - Nasal spray
- Ear drops
- Eye drops
- Ointment
- Hydrogel
- Nanosphere suspension
- Mucoadhesive microdisc (microsphere tablet)
Urogenital - Ointment
- Pessary (vaginal suppository)
- Vaginal ring
- Vaginal douche
- Intrauterine device (IUD)
- Extra-amniotic infusion
- Intravesical infusion
Rectal (enteral) - Ointment
- Suppository
- Enema (Solution • Hydrogel)
- Murphy drip
- Nutrient enema
Dermal Injection / Infusion
(into tissue/blood)- Intracavernous
- Intravitreal
- Intra-articular or intrasynovial injection
- Transscleral
- Intracerebral
- Intrathecal
- Epidural
Additional explanation: Mucous membranes are used by the human body to absorb the dosage for all routes of administration, except for "Dermal" and "Injection/Infusion".
Administration routes can also be grouped as Topical (local effect) or Systemic (defined as Enteral = Digestive tract/Rectal, or Parenteral = All other routes).Routes of administration by organ system Gastrointestinal Respiratory system Pulmonary • NasalVisual system / Auditory system Ocular (Ocular-topical / Intravitreal / Transscleral) • Otologic (Oto-topical)Reproductive system Intracavernous • Intravaginal • Intrauterine (Extra-amniotic)Urinary system IntravesicalPeritoneum Central nervous system Intracerebral • Intrathecal • EpiduralCirculatory system Musculoskeletal system Skin Epicutaneous • Intradermal • SubcutaneousCategories:- Smoking cessation
- Transdermal patches
Wikimedia Foundation. 2010.